Geminally di-substituted NSAID derivatives as Abeta 42 lowering agents

Details for Australian Patent Application No. 2004206796 (hide)

Owner Merck & Co., Inc.

Inventors Munoz, Benito; Prasit, Petpiboon; Stock, Nicholas Simon

Agent Spruson & Ferguson

Pub. Number AU-A-2004206796

PCT Pub. Number WO2004/064771

Priority 60/439,965 14.01.03 US; 60/439,847 14.01.03 US

Filing date 9 January 2004

Wipo publication date 5 August 2004

International Classifications

C07D 257/04 Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

Event Publications

14 July 2005 PCT application entered the National Phase

  PCT publication WO2004/064771 Priority application(s): WO2004/064771

5 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004206812-3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

2004206794-Substituted alkyl amido piperidines